References
- Health Insurance Review & Assessment Service. Statistics on Treatment Amount. 2005-2011. Available at http://www. hira.or.kr/dummy.do?pgmid=HIRAA020045030000. Accessed on March 2, 2013.
- Press Release of Ministry of Health & Welfare. The Measures to reform the drug-pricing policy and develop the pharmaceutical industry. Available at http://www.mw.go.kr/ front_new/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ ID=0403&page=96&CONT_SEQ=258276. Accessed on March 2, 2013.
- Shin YS. Social Insurance: For a Restructured Basic Oldage Pension and a Sustainable Health Insurance. Health and Welfare Policy Forum 2010; 8: 48-54.
- Navarro RP. Managed Care Pharmacy Practice Second Edition. Massachussetts, U.S.: Jones and Bartlett Publishers 2009: 36-40.
- Medco. 2007 Drug trend report. Available at http:// citeseerx.ist.psu.edu/viewdoc/download;jsessionid=A23DF 853DE8761F475DC1549FFCA7E1D?doi=10.1.1.175.8475& rep=rep1&type=pdf. Accessed on May 1, 2014.
- Kaiser Family Foundation, Health Research & Educational Trust. Employer Health Benefits. 2012 Annual Survey. Available at http://kaiserfamilyfoundation.files.wordpress. com/2013/03/8345-employer-health-benefits-annual-surveyfull- report-0912.pdf. Accessed on August 20, 2013.
- Rector TS, Finch MD, Danzon PM, et al. Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications. Medical Care. 2003; 41(3): 398-406.
- Joyce GF, Escarce JJ, Solomon MD, et al. Employer Drug Benefit Plans and Spending on Prescription Drugs. Journal of the American Medical Association. 2002; 288(14): 1733-9. https://doi.org/10.1001/jama.288.14.1733
- The Korea Institute for Health and Social Affairs. Policy Measures to Differentiate Drug Insurance Benefits by the Therapeutic Characteristics of Drugs 2004.
- Health Insurance Policy Institute. Development of a Road Map for Systematical Management of Pharmacy Benefit Expenditure of National Health Insurance 2012.
- Korea Centers for Disease Control & Prevention. The Fourth Korea National Health & Nutrition Examination Survey, The Second Year (2008). 2009.
- Korean Diabetes Association / Korean Diabetes Research Foundation / International Conference on Diabetes and Metabolism 2013. Diabetes Fact Sheet in Korea 2013. Available at http://www.diabetes.or.kr/temp/diabetes_factsheet_ 2013111.pdf. Accessed on Mar 1, 2014.
- Press Release of Health Insurance Review & Assessment Service. Average Annual Out-of-pocket Pharmacy Expenditure per Outpatient is 80,000 KRW. Available at http://hira.or.kr/ dummy.do?pgmid=HIRAA020041000000&cmsurl=/cms/ notice/02/news,1,list,45.html. Accessed on June 19, 2013.
- Press Release of Ministry of Health & Welfare. National Health Insurance, Coverage Expansion in the Field of Cancer and Dentistry. Available at http://www.mohw.go.kr/ front_new/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ ID=0403&page=1&CONT_SEQ=215388&SEARCHKEY= TITLE&SEARCHVALUE=%BA%B8%C0%E5%BC%BA. Accessed on June 19, 2013.
- National Health Insurance Act Enforcement Ordinance (Presidential Decree No. 24588, Effective on 2013.7.1) Article 19, Attachment 2. Available at http://www.nhis.or. kr/portal/site/main/MENU_WBDDD01. Accessed on July 1, 2013.
- National Health Insurance Act Enforcement Regulation (Ministry of Health & Welfare Decree No. 200, Effective on 2016.6.28) Article 13, Attachment 4. Available at http:// www.nhis.or.kr/portal/site/main/MENU_WBDDD01. Accessed on June 28, 2013.
- National Drug Formulary as of 2010.8.1 (Reflection of Ministry of Health & Welfare notification No. 2010-55). Available at http://www.hira.or.kr/dummy.do?pgmid= HIRAA030014050000&cmsurl=/cms/information/02/01/06/ 1200786_25372.html&subject=2010.8.1+%ED%98%84%E C%9E%AC+%EC%95%BD%EC%A0%9C%EA%B8%89 %EC%97%AC%EB%AA%A9%EB%A1%9D%282010.7.2 7+%EA%B3%A0%EC%8B%9C+%EB%B0%98%EC%98 %81%29. Accessed on August 1, 2013.
- Press Release of Ministry of Food and Drug Safety. Stop Use of Rosiglitazone, and Limited Use for Patients Who Have No Alternatives. Available at http://www.mfds.go.kr/ index.do?mid=675&seq=13453&cmd=v. Accessed on November 2, 2013.
- IMS Health Korea. MAT-12/2009 ST-CNT.UNIT. 2009.
- Amendment of 'Calculation Standard of Patient Out-of Pocket Expense' (Ministry of Health & Welfare No. 2011- 86). Available at http://www.mw.go.kr/front_new/jb/sjb0402 vw.jsp?PAR_MENU_ID=03&MENU_ID=030402&page=1 &CONT_SEQ=258099&SEARCHKEY=TITLE&SEARCH VALUE. Accessed on December 1st, 2011.
- Regulation on Drug Safety (Ordinance of the Prime Minister No. 1022, Effective on 2013.3.23) Item 3 of Clause 1 of Article 4. Available at http://www.law.go.kr/lsInfoP.do?lsiSeq =137939&efYd=20130323#0000. Accessed on August 20, 2013.
- Lee EK, Kim DS. Analysis of Perception on the Bioequivalence-assured Generic Drugs. Kor J Clin Pharm 2006; 16(2): 139-46.
- Medicare.gov. The official U.S. Government Site for Medicare. Available at http://www.medicare.gov/part-d/costs/ coverage-gap/part-d-coverage-gap.html. Accessed on Nov 2013.
- Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care. 2005; 11(5): S170-6.
- Huskamp HA, Deverka PA, Epstein AM, et al. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003; 349(23): 2224-32. https://doi.org/10.1056/NEJMsa030954
- Lee IH, Bloor K, Hewitt C, et al. The effects of new pricing and copayment schemes for pharmaceuticals in South Korea. Health Policy. 2012; 104(1): 40-9. https://doi.org/10.1016/j.healthpol.2011.09.003